Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder with Hyperactivity

Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.

1,408 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder with Hyperactivity trial results

Completed

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

NCT01338818

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder, +8 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Spring Valley, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 48 locations
View Trial Details
Completed

Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

NCT01259492

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder, +2 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Spring Valley, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 68 locations
View Trial Details
Completed

A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT01886469

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder, +2 more
Locations
  • Saskatoon Centre for Patient-Oriented Research, Royal University Hospital, Room 5681, C Wing Saskatoon, Saskatchewan, Canada
View Trial Details
Completed

A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

NCT01933880

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Beijing, China
  • Changchun, China
  • Guangzhou, China
  • Hangzhou, China
View Trial Details

Related conditions